Bactroban and Septra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bactroban (mupirocin) and Septra (sulfamethoxazole; trimethoprim). Common drug interactions include headache among females and crohn's disease among males.

The phase IV clinical study analyzes what interactions people have when they take Bactroban and Septra. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

40 people who take Bactroban and Septra together, and have interactions are studied.

Bactroban and Septra drug interactions.

What are the common drug interactions of Bactroban and Septra, by gender? *:

female:

  1. Headache (pain in head)
  2. Renal failure (kidney dysfunction)
  3. Sinusitis (inflammation of sinus)
  4. Anaemia (lack of blood)
  5. Vomiting
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Back pain
  9. Chest pain
  10. Chills (felling of cold)

male:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Groin pain
  5. Ileitis (inflammation of the ileum)
  6. Inflammatory bowel disease
  7. Irritable bowel syndrome
  8. Multi-organ disorder (multiple organ disease)
  9. Pain in extremity
  10. Abdominal pain upper

What are the common drug interactions of Bactroban and Septra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Upper respiratory tract infection

10-19:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

20-29:

  1. Anaemia (lack of blood)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Cardiac disorder
  5. Chest pain
  6. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  7. Decreased appetite
  8. Fatigue (feeling of tiredness)
  9. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

30-39:

  1. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  2. Injury
  3. Overdose
  4. Wound infection staphylococcal

40-49:

n/a

50-59:

  1. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  2. Joint swelling
  3. Neoplasm progression (growth of tumour)
  4. Oedema (fluid collection in tissue)
  5. Rash
  6. Respiratory tract infection
  7. Sinusitis (inflammation of sinus)
  8. Chills (felling of cold)
  9. Drug ineffective
  10. Headache (pain in head)

60+:

  1. Rectal ulcer (ulcer of rectum)
  2. Pleural effusion (water on the lungs)
  3. Tumour pain
  4. Nausea (feeling of having an urge to vomit)
  5. Cardiac failure congestive
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Death
  8. Dizziness
  9. Ear pain
  10. Fall

What are the existing conditions these people have? *

  1. Pain: 15 people, 37.50%
  2. Acne (skin problems that cause pimples): 10 people, 25.00%
  3. Allergic Sinusitis: 8 people, 20.00%
  4. Sinusitis (inflammation of sinus): 8 people, 20.00%
  5. Constipation: 8 people, 20.00%
  6. Gastric Ulcer (stomach ulcer): 8 people, 20.00%
  7. Asthma: 6 people, 15.00%
  8. Indigestion: 5 people, 12.50%
  9. Allergic Rhinitis: 5 people, 12.50%
  10. Back Pain: 5 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Bactroban and Septra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bactroban and Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactroban and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Septra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin and sulfamethoxazole; trimethoprim (the active ingredients of Bactroban and Septra, respectively), and Bactroban and Septra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: